Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2002 Oct;20(10):2069-79.
doi: 10.1097/00004872-200210000-00028.

Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial

Astrid E Fletcher  1 , Christopher J Bulpitt, Lutgarde Thijs, Jaakko Tuomilehto, Riitta Antikainen, Alfredo Bossini, John Browne, Joseph Duggan, Kalina Kawecka-Jaszcz, Paula Kivinen, Cinzia Sarti, Laura Terzoli, Jan A Staessen; Syst-Eur Trial Investigators
Affiliations
Clinical Trial

Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial

Astrid E Fletcher et al. J Hypertens. 2002 Oct.

Abstract

Objective: To compare quality of life in elderly patients with isolated systolic hypertension allocated randomly to groups to receive placebo or active treatment in the Systolic Hypertension in the Elderly Trial.

Design: Double-blind randomized controlled trial.

Methods: Patients aged 60 years were allocated randomly to groups to receive first-line treatment with nitrendipine (with second- and third-line enalapril and hydrochlorothiazide) or placebo. Trained interviewers administered trail-making tests (Trail A and B), Brief Assessment Index (a measure of depressed mood) and four subscales from the Sickness Impact Profile (Ambulation, Social Interaction, Sleep and Rest, and Home work).

Results: Six hundred and ten patients completed a baseline and at least one follow-up questionnaire. Trail-making scores were slower in actively treated patients, especially in the first 6 months of follow-up when the between-group effect sizes were 0.25 [95% confidence interval (CI) 0.07 to 0.43] for Trail-making A and 0.13 (95% CI -0.05 to 0.31) for Trail-making B. Across the 4 years of follow-up, patients receiving active treatment were more likely to report problems on the Social Interaction scale than were placebo-treated patients (odds ratio 1.32, 95% CI 1.02 to 1.69), equivalent to a 7% difference. There were no significant differences between active and placebo treatment in the other Sickness Impact Profile dimensions or in the measure of depression.

Conclusions: Active treatment in the Systolic Hypertension in Europe trial was associated with some small adverse impacts on quality of life.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

Substances

LinkOut - more resources